KATX.PK 0.085 0.00 VCTY.PK 0.0079 0.00 SFIN.PK 0.078 0.00 CEHC.PK 0.018 0.00 LGTT.PK 0.01 0.00 ZVTK.OB 0.0007 0.00 ERFW.OB 0.05 0.00 WTKN.OB 0.0033 0.00
>

Author Archives: Stock Marketing, Inc.

By Stock Marketing, Inc. | Published: August 20, 2010, 8:56 am
CHTP Chelsea Therapeutics International, Ltd. LChelsea Therapeutics is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases. Chelsea’s most advanced drug candidate, Northera(TM) (droxidopa), is an orally active synthetic precursor of norepinephrine initially being developed for the treatment of neurogenic orthostatic hypotension. In addition to [...]
Copyright © 2010 Stock Marketing Inc. All Rights Reserved
Produced by Technotic Media Inc.